Cytek Biosciences Inc (CTKB)
Receivables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 176,629 | 201,210 | 197,710 | 200,786 | 193,014 | 183,117 | 175,594 | 166,060 | 164,036 | 154,594 | 148,493 | 138,742 | 127,950 | 119,675 | 110,395 | 99,123 | 92,839 |
| Receivables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Receivables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Receivables turnover = Revenue (ttm) ÷ Receivables
= $176,629K ÷ $—K
= —
The receivables turnover ratio for Cytek Biosciences Inc has been consistently reported as "—", indicating that the specific data for this ratio is not provided in the financial statements for the periods mentioned (from December 31, 2020, to December 31, 2024).
The receivables turnover ratio is a financial metric that measures a company's efficiency in collecting outstanding receivables from its customers during a specific period. A higher turnover ratio typically indicates that the company is effectively collecting payments from its customers, while a lower ratio may suggest inefficiencies in accounts receivable management.
Without specific values for the receivables turnover ratio, it is challenging to assess Cytek Biosciences Inc's ability to efficiently manage its accounts receivable and collect payments from customers. Further analysis and additional information would be necessary to evaluate the company's performance in this aspect of its operations.
Peer comparison
Dec 31, 2024